News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,542 Results
Type
Article (39425)
Company Profile (249)
Press Release (653868)
Section
Business (204048)
Career Advice (2006)
Deals (35408)
Drug Delivery (93)
Drug Development (80963)
Employer Resources (169)
FDA (16138)
Job Trends (14831)
News (344922)
Policy (32479)
Tag
Academia (2538)
Alliances (49331)
Alzheimer's disease (1320)
Approvals (16125)
Artificial intelligence (209)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (177)
Breast cancer (231)
Cancer (1778)
Cardiovascular disease (132)
Career advice (1670)
CAR-T (130)
Cell therapy (371)
Clinical research (65360)
Collaboration (690)
Compensation (383)
COVID-19 (2568)
C-suite (174)
Data (1700)
Diabetes (222)
Diagnostics (6299)
Earnings (85674)
Employer resources (145)
Events (111128)
Executive appointments (584)
FDA (17089)
Funding (620)
Gene therapy (255)
GLP-1 (657)
Government (4362)
Healthcare (18783)
Infectious disease (2685)
Interviews (311)
IPO (16467)
Job creations (3627)
Job search strategy (1421)
Layoffs (440)
Legal (7890)
Lung cancer (259)
Manufacturing (243)
Medical device (13281)
Medtech (13286)
Mergers & acquisitions (19336)
Metabolic disorders (573)
Neuroscience (1740)
NextGen: Class of 2025 (6510)
Non-profit (4476)
Northern California (2194)
Obesity (314)
Opinion (196)
Patents (174)
People (56898)
Phase I (20352)
Phase II (28789)
Phase III (21438)
Pipeline (792)
Postmarket research (2563)
Preclinical (8588)
Radiopharmaceuticals (242)
Rare diseases (331)
Real estate (5897)
Regulatory (21984)
Research institute (2314)
Resumes & cover letters (349)
Southern California (1876)
Startups (3569)
United States (19222)
Vaccines (621)
Weight loss (214)
Date
Today (150)
Last 7 days (809)
Last 30 days (2788)
Last 365 days (34429)
2025 (5436)
2024 (35220)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35019)
2017 (32110)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Arizona (211)
Asia (37552)
Australia (6140)
California (4989)
Canada (1752)
China (411)
Colorado (227)
Connecticut (237)
Europe (80497)
Florida (734)
Georgia (171)
Illinois (463)
Indiana (272)
Japan (126)
Maryland (760)
Massachusetts (3789)
Michigan (200)
Minnesota (345)
New Jersey (1411)
New York (1425)
North Carolina (857)
Northern California (2194)
Ohio (175)
Pennsylvania (1136)
South America (1093)
Southern California (1876)
Texas (727)
Utah (154)
Washington State (476)
693,542 Results for "cellecta inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Cellecta, Inc. Launches DriverMap™ Adaptive Immune Receptor (AIR) Human RNA Spike-In Controls to Ensure Consistent Quality and Optimal Performance of TCR and BCR Profiling Assays
Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor (AIR) Human RNA Spike-In Premixed Controls, the first commercially available collection of synthetic mRNA constructs that can serve as universal controls for commercial or home-brewed AIR repertoire sequencing (AIR-Seq, TCR-seq and BCR-seq) assays based on multiplex RT-PCR or 5' RACE PCR techniques.
April 4, 2024
·
3 min read
Biotech Bay
Cellecta, Inc. Launches Genome-Wide CRISPR Chicken and Pig Knockout Libraries
Cellecta, Inc. announced the release of new pooled, single-module, CRISPR genome-wide knockout libraries for chicken and pig.
October 9, 2023
·
3 min read
Biotech Bay
Cellecta, Inc. Launches DriverMap™ Adaptive Immune Receptor (AIR) Mouse RNA TCR and BCR Kits for Sensitive Immune Repertoire Profiling
Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor (AIR) Mouse RNA TCR and BCR kits.
November 16, 2023
·
3 min read
Biotech Bay
Cellecta, Inc. Launches DriverMap™ Adaptive Immune Receptor (AIR) Assay to Provide Greater Insights into Immune Repertoire Diversity by Profiling T-Cell and B-Cell Receptor Variability in Genomic DNA
Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor DNA (AIR-DNA) TCR and BCR kits which provide rapid, single-tube PCR-based assays to analyze the genomic diversity of receptors from T-cells or B-cells from a wide range of sample types, including whole blood, tissue biopsies, FFPE and more.
April 12, 2023
·
3 min read
Biotech Bay
Cellecta, Inc. Launches DriverMap™ Adaptive Immune Receptor (AIR) TCR and BCR Kits for Comprehensive Immune Repertoire Profiling
Cellecta, Inc. announced the launch of the DriverMap™ Adaptive Immune Receptor TCR and BCR kits, a family of multiplex-PCR, NGS-based assays that enable profiling of up to all seven T-cell receptor and B-cell receptor chains from the same sample, in a single tube, without need of specialized equipment.
October 5, 2022
·
3 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Press Releases
Moss Genomics Inc. Announces Leadership Changes
February 26, 2025
·
5 min read
Press Releases
Albertsons Companies, Inc. Announces CEO Succession Plan
March 3, 2025
·
8 min read
Press Releases
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 12, 2025
·
6 min read
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
1 of 69,355
Next